PA
CRS icon

PharVision Advisers’s Carpenter Technology CRS Stock Holding History

PharVision Advisers’s Portfolio CRS Stock Details CRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,303
Closed -$320K – 741
2025
Q3 		$320K Buy
+1,303
New +$333K 0.18% 190

Other funds holding CRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
SP
SurgoCap Partners New York $2.99B AUM 39.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's CRS Position: Q4 2025 in Review

PharVision Advisers sold out of Carpenter Technology (CRS) in Q4 2025, closing a stake of 1,303 shares — an estimated $320K sold.

PharVision Advisers first reported a position in CRS in Q3 2025 and held it in 1 quarter. The position peaked at $320K in Q3 2025. 626 funds tracked by Wall St. Rank hold CRS as of Q4 2025.

  • PharVision Advisers reported no remaining Carpenter Technology position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 1,303 Carpenter Technology shares in Q4 2025, an estimated $320K.
  • PharVision Advisers first reported a position in Carpenter Technology in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Carpenter Technology position peaked at $320K in Q3 2025.
  • 626 funds tracked by Wall St. Rank held Carpenter Technology as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.